Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts
Press release – No. 19 / 2026 Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts Builds on the Metabolic Frontier 2030 strategy, advancing its ambition to become a leader in obesity and metabolic health…
There's one pharma-linked stock most investors have never heard of. It's on Josh Brown's list
(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — There's a good chance you've never heard of West Pharmaceutical Services (WST). There's an even better chance you've…
Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients
A single dose of NovoBioJect increased the active form of methotrexate inside patients' immune cells by 38%, a first step toward a potential next-generation first-line treatment for rheumatoid arthritis First clinical proof of principle. In an…
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
Whether it's biotech stocks or regular pharmaceutical stocks, when investors buy a particular name in healthcare, they are making a wager on a single company's pipeline. However, there is one unique name within this space that enables investors to…
Orimed Pharma launches PrBALANSYA, Canada's only escitalopram oral solution
Orimed Pharma, part of the JAMP Pharma Group, launches BALANSYA, the only escitalopram oral solution available in Canada. The 2 mg/mL formulation gives healthcare professionals an oral liquid option when prescribing escitalopram. Following the…
China eyes competition with Big Pharma over next 5 years
China is making it clear that it wants to become a powerhouse on a par with large Western pharmaceutical companies in the near future, and not just strike licensing deals for promising new drug candidates. Why it matters: Some experts warn that big…
Zealand Pharma announces Boehringer Ingelheim's survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
Company announcement – No. 52 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type…
OnDosis and Adare Pharma Solutions announce strategic collaboration to advance OnDosis's lead U.S. ADHD program
OnDosis AB ('OnDosis'), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ('Adare'), a technology-driven…
Arcus agrees to buy SK Pharma from Syz Capital and Saturnus Capital
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated 'Moderate Buy' by Wall Street Analysts
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) has earned a consensus recommendation of 'Moderate Buy' from the six research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock…
Nxera Announces Successful Resolution of miniG Patent Infringement Action
Tokyo, Japan and Cambridge and London, UK, 30 September 2026 – Nxera Pharma Co., Ltd. (“Nxera Pharma” or “the Company”; TSE 4565) announces that its wholly owned subsidiary Nxera Pharma UK Limited…
Boehringer, Zealand Obesity Drug's 13% Weight Loss Disappoints
Boehringer Ingelheim GmbH 's and Zealand Pharma A/S 's experimental obesity drug survodutide helped patients with diabetes shed as much as 13.1% of their weight, disappointing investors. Zealand shares fell as much as 13% in Copenhagen trading…
Aurobindo arm Acrotech Biopharma forays into U.S. dermatology market with atopic dermatitis ointment
Aurobindo Pharma subsidiary Acrotech Biopharma has launched Adquey (difamilast 1%) ointment, a non-steroidal topical treatment for mild-to-moderate atopic dermatitis, in the U.S. The product will compete in a market estimated to be around $1.3…
Gavin Newsom Signs Bill Banning 'Robo Bosses' as Part of California Crackdown on AI
A day after President Donald Trump had lunch with some of the nation's top AI executives, California Gov. Gavin Newsom signed a slate of bills Wednesday aimed at putting new guardrails on the technology. Chief among them was the “ No Robo…
TPG: Weak Realizations Are Hiding A Much Stronger Fee Business (NASDAQ:TPG)
TPG Inc. is rated Buy with a $55 price target, despite a sharp decline from its 52-week high. TPG's fee-related earnings surged 43% and fee-earning AUM rose 24%, while weak realizations drove the stock lower. Approximately $51.7 billion of AUM is…
Receive a Daily briefing on Pharma Industry News
Get Started